Loading…

Results of a randomized phase IIb trial of nelipepimut-S + trastuzumab vs trastuzumab to prevent recurrences in high-risk HER2 low-expressing breast cancer patients

Saved in:

Bibliographic Details
Published in:	Clinical cancer research 2020-02, Vol.26 (11), p.2515-2523
Main Authors:	Clifton, G. Travis, Hale, Diane F., Vreeland, Timothy J., Hickerson, Annelies T., Litton, Jennifer K., Alatrash, Gheath, Murthy, Rashmi K., Qiao, Na, Philips, Anne, Lukas, Jason, Holmes, Jarrod P., Peoples, George E., Mittendorf, Elizabeth A.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!